Abstract

Review Article

Tolerance to extreme doses of psychoactive substances

DG Baitubayеv* and MD Baitubayeva

Published: 31 December, 2021 | Volume 5 - Issue 1 | Pages: 027-031

The article shows that the current level of physiology does not disclose the biological mechanisms of the organism’s transition from one range to adapt to a higher one with an increase in the regular forces of the stimulus above sub-extreme. A new trend in the physiology of adaptation - proqredient adaptation, explains the mechanism of increasing the tolerance of the organism, with dependence on psychoactive substances (PAS). Scientific has reasonably shown that depending on the organism from PAS - not the disease, and the states like proqredient adaptation.

Read Full Article HTML DOI: 10.29328/journal.jatr.1001019 Cite this Article Read Full Article PDF

Keywords:

Hypertrophy of the endocrine system; A state of regular, unfinished stresses; A progredient adaptation

References

  1. Zaichik AS, Churilov LP. General pathophysiology. St. Petersburg. 2005; 525: 23-26.
  2. Korobkov AV, Bashkirov AA, Vetchinkina KT. Normal physiology. Chapter 28 Physiology of adaptation. Moscow: High School, 1980; 560: 499.
  3. Pyatnitskaya IN. Clinical Drug Addiction. Moscow: Medicine, Leningrad branch. 1975. 333: 3-6; 22-45.47-55; 255-256, 261 -263; 268-274.
  4. Pyatnitskaya IN. Alcohol abuse and the initial stage of alcoholism. Moscow: Medicine. 1988. 286: 77-80.
  5. Smirnov VM, Yakovlev VN. Physiology of the central nervous system. Moscow: Academy. 2004. 184-185; 250-251.
  6. Kirillov OI. Stress hypertrophy of the adrenal glands. Moscow: Science. 1994; 176.

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

  • Neurotoxicity related exposure to ambient nanoparticles
    Mojtaba Ehsanifar*, Zeinab Montazeri and Mehravar Rafati Mojtaba Ehsanifar*,Zeinab Montazeri,Mehravar Rafati. Neurotoxicity related exposure to ambient nanoparticles. J Neurosci Neurol Disord. 2022: doi: 10.29328/journal.jnnd.1001060; 6: 005-010
  • Pediatric brainstem glioma
    Ghita Hatim*, Tarik Chekrine, Majdouline Houjami, Mouna Boughafour, Zineb Bouchbika, Nadia Benchakroun, Hassan Jouhadi, Nezha Tawfiq, Abdelatif Benider and Souha Sahraoui Ghita Hatim*,Tarik Chekrine,Majdouline Houjami,Mouna Boughafour,Zineb Bouchbika,Nadia Benchakroun,Hassan Jouhadi,Nezha Tawfiq,Abdelatif Benider,Souha Sahraoui. Pediatric brainstem glioma. J Neurosci Neurol Disord. 2022: doi: 10.29328/journal.jnnd.1001059; 6: 001-004
  • SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature
    Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Maria Ximena Cardona-Blanco, Victor Leal-Martínez, Emilio Abuabara-Franco, Nehomar Pajaro-Galvis*, Jose Cabrales, José Correa, Manuel Cueto, Amable Duran, Alejandro Castellanos, Javier Enamorado, José Bohórquez, Isabella Uparella, Julio Zuñiga, Abraham Chagui, Alfonso Ramos and Luis Lara Jorge Rico-Fontalvo,Rodrigo Daza-Arnedo,Maria Ximena Cardona-Blanco,Victor Leal-Martínez,Emilio Abuabara-Franco,Nehomar Pajaro-Galvis*,Jose Cabrales,José Correa,Manuel Cueto,Amable Duran,Alejandro Castellanos,Javier Enamorado,José Bohórquez,Isabella Uparella,Julio Zuñiga,Abraham Chagui,Alfonso Ramos,Luis Lara. SGLT2 Inhibitors and nephroprotection in diabetic kidney disease: From mechanisms of action to the latest evidence in the literature. J Clini Nephrol. 2020: doi: 10.29328/journal.jcn.1001058; 4: 044-055
  • Neurosciences and dynamical system theory: some short remarks
    Giuseppe Iurato* Giuseppe Iurato*. Neurosciences and dynamical system theory: some short remarks. J Neurosci Neurol Disord. 2021: doi: 10.29328/journal.jnnd.1001058; 5: 094-095
  • Intrasellar psammomatous meningioma: a case report and review of the literature
    Luca Riccioni*, Antonio Balestrieri, Fuschillo Dalila, Maria Teresa Nasi and Luigino Tosatto Luca Riccioni*,Antonio Balestrieri,Fuschillo Dalila,Maria Teresa Nasi,Luigino Tosatto. Intrasellar psammomatous meningioma: a case report and review of the literature. J Neurosci Neurol Disord. 2022: doi: 10.29328/journal.jnnd.1001061; 6: 011-015

Read More

Most Viewed

Read More